Page 27 - GALENIKA MEDICAL JOURNAL

10. Yuen KCJ. Adult growth hormone deficiency guidelines: more difficult 24. Van Bunderen CC, Glad C, Johannsson G, Olsson DS. Personalized
than it seems to incorporate into clinical practice universally. Eur J approach to growth hormone replacement in adults. Arch Endocrinol
Endocrinol. 2021 Apr;184(4):C5-C7. Metab. 2019 Nov-Dec;63(6):592-600.
11. Götherström G, Johannsson G, Svensson J. Effects of 18 months of GH 25. Höybye C. Comparing treatment with daily and long-acting growth
replacement on cardiovascular risk factors and quality of life in GH hormone formulations in adults with growth hormone deficiency:
deficient adults; a randomized controlled trial using a fixed very low Challenging issues, benefits, and risks. Best Pract Res Clin Endocrinol
and a standard dose of GH. Growth Horm IGF Res. 2022 Dec;67:101510. Metab. 2023 Dec;37(6):101788.
12. Elbornsson M, Horvath A, Götherström G, Bengtsson BÅ, Johannsson G, 26. Yuen KCJ, Biller BMK, Radovick S, Carmichael JD, Jasim S, Pantalone KM,
Svensson J. Seven years of growth hormone (GH) replacement improves et al. American Association of Clinical Endocrinologists and American
quality of life in hypopituitary patients with adult-onset GH deficiency. College of Endocrinology Guidelines for management of growth
Eur J Endocrinol. 2017 Feb;176(2):99-109. hormone deficiency in adults and patients transitioning from pediatric
to adult care. Endocrine Practice. 2019; 25:1191-232.
13. Stojanovic M, Popevic M, Pekic S, Doknic M, Miljic D, Medic-Stojanoska
M, et al. Serum Insulin-Like Growth Factor-1 (IGF-1) Age-Specific 27. Boguszewski CL. Safety of long-term use of daily and long-acting
Reference Values for Healthy Adult Population of Serbia. Acta growth hormone in growth hormone-deficient adults on cancer risk.
Endocrinol (Buchar). 2021 Oct-Dec;17(4):462-71. Best Pract Res Clin Endocrinol Metab. 2023 Dec;37(6):101817.
14. Doknic M, Miljic D, Pekic S, Stojanovic M, Savic D, Manojlovic-Gacic E, 28. Bolier M, Van der Lelij AJ, Janssens GO, Van den Heuvel-Eibrink MM,
et al. Single center study of 53 consecutive patients with pituitary stalk Neggers SJCMM. Long-term safety of growth hormone replacement
lesions. Pituitary. 2018 Dec;21(6):605-14. therapy in survivors of cancer and tumors of the pituitary region.
Endocr Relat Cancer. 2023 Jun 2;30(7):e230026.
15. Garcia JM, Biller BMK, Korbonits M, Popovic V, Luger A, Strasburger CJ,
et al. Sensitivity and specificity of the macimorelin test for diagnosis of 29. Di Somma C, Scarano E, Arianna R, Romano F, Lavorgna M, Serpico
AGHD. Endocr Connect. 2021 Jan;10(1):76-83. D, et al. Long-Term Safety of Growth Hormone Deficiency Treatment
in Cancer and Sellar Tumors Adult Survivors: Is There a Role of GH
16. Gasco V, Ferrero A, Bisceglia A, Prencipe N, Cambria V, Bioletto F, et Therapy on the Neoplastic Risk? J Clin Med. 2023 Jan 13;12(2):662.
al. The Cut-off Limits of Growth Hormone Response to the Insulin
Tolerance Test Related to Body Mass Index for the Diagnosis of Adult 30. Garmes HM, Castillo AR, Monte Alegre S, de Souza AL, Atala YB, Zantut-
Growth Hormone Deficiency. Neuroendocrinology. 2021;111(5):442-50. Wittmann DE. Childhood-Onset GH Deficiency versus Adult-Onset
GH Deficiency: Relevant Differences Regarding Insulin Sensitivity.
17. Rochira V, Mossetto G, Jia N, Cannavo S, Beck-Peccoz P, Aimaretti G, Metabolites. 2022 Dec 11;12(12):1251.
et al. Analysis of characteristics and outcomes by growth hormone
treatment duration in adult patients in the Italian cohort of the 31. Spaziani M, Tarantino C, Tahani N, Gianfrilli D, Sbardella E, Isidori AM,
Hypopituitary Control and Complications Study (HypoCCS). J Endocrinol et al. Clinical, Diagnostic, and Therapeutic Aspects of Growth Hormone
Invest. 2018 Nov;41(11):1259-66. Deficiency During the Transition Period: Review of the Literature. Front
Endocrinol (Lausanne). 2021 Feb 24;12:634288.
18. Elbornsson M, Götherström G, Bosæus I, Bengtsson BÅ, Johannsson
G, Svensson J. Fifteen years of GH replacement improves body 32. Yuen KCJ, Alter CA, Miller BS, Gannon AW, Tritos NA, Samson SL, et al.
composition and cardiovascular risk factors. Eur J Endocrinol. 2013 Apr Adult growth hormone deficiency: Optimizing transition of care from
15;168(5):745-53. pediatric to adult services. Growth Horm IGF Res. 2021 Feb;56:101375.
19. Appelman-Dijkstra NM, Rijndorp M, Biermasz NR, Dekkers OM, Pereira 33. Doknic M, Stojanovic M, Soldatovic I, Milenkovic T, Zdravkovic V, Jesic
AM. Effects of discontinuation of growth hormone replacement in adult M, et al. Mapping the journey of transition: a single-center study of
GH-deficient patients: a cohort study and a systematic review of the 170 childhood-onset GH deficiency patients. Endocr Connect. 2021 Aug
literature. Eur J Endocrinol. 2016 Jun;174(6):705-16. 13;10(8):935-946.
20. Shimon I, Badiu C, Bossowski A, Doknic M, Dzivite-Krisane I, Hána V, et
al. Adult growth hormone deficiency in CEE region: Heterogeneity of
the patient pathway. Growth Horm IGF Res. 2019 Jun-Aug;46-47:44-9. Declaration of interest statement: None
21. Shen YY, Ma JN, Ren ZY, Liu J, Zhou XY, Xie XR, et al. Effects of 18 Months Received: 19. 02. 2024.
of Growth Hormone Replacement Therapy on Bone Mineral Density in Accepted: 29. 02. 2024.
Patients with Adult Growth Hormone Deficiency: A Retrospective Study.
Int J Endocrinol. 2023 Mar 31;2023:4988473. Online: 31. 03. 2024.
22. Mericq V, Iñiguez G, Pinto G, Gonzalez-Briceño LG, Samara-Boustani D,
Thalassinos C, et al. Identifying patient-related predictors of permanent
growth hormone deficiency. Front Endocrinol (Lausanne). 2023 Oct
10;14:1270845.
23. Johannsson G, Touraine P, Feldt-Rasmussen U, Pico A, Vila G, Mattsson
AF, et al. Long-term Safety of Growth Hormone in Adults With Growth
Hormone Deficiency: Overview of 15 809 GH-Treated Patients. J Clin
Endocrinol Metab. 2022 Jun 16;107(7):1906-19.

REVIEW PAPER Galenika Medical Journal, 2024; 3(9):19-25. 25